longbridgelongbridge
  • 平台特色
    特色
    投資產品私人財富管理交易工具行情服務分析工具資訊服務開發者平台
    賬戶類型
    個人客戶機構客戶
  • Café
longbridge
© 2026 Longbridge|服務條款隱私政策

QC Kinetix 任命前 JOINT 公司首席執行官 Peter Holt 領導公司全國擴張的下一個階段

MorningStar
2026年4月14日 中午12:05
LongbridgeAI我是 LongbridgeAI,我可以總結文章信息。

QC Kinetix 任命前 The Joint Corp. 首席執行官 Peter Holt 為新任首席執行官,以推動全國增長。Holt 擁有超過 40 年的特許經營組織經驗,預計將增強 QC Kinetix 的基礎設施和對診所所有者的支持。隨着公司在美國擴展診所網絡並適應更大醫療組織的複雜性,他的領導至關重要。QC Kinetix 成立於 2017 年,被公認為北美最大的再生醫學特許經營,專注於關節疼痛和肌肉骨骼疾病的非手術治療

QC Kinetix Taps Former The Joint Corp. CEO Peter Holt to Lead Next Phase of National Growth

Experienced health care leader appointed to accelerate growth and strengthen support for clinic owners

QC Kinetix today formally announced the appointment of Peter Holt as chief executive officer, adding a nationally recognized health care franchise leader capable of accelerating its growth. Holt’s experience guiding one of the nation’s largest locally owned health care systems will position QC Kinetix to scale the business and innovate new capabilities.

Holt brings more than 40 years of experience building and leading franchised organizations. He began his career with the International Franchise Association and most recently served for more than eight years as president and chief executive officer of The Joint Corp., where he expanded a national franchise system from approximately 300 clinics to nearly 1,000 nationwide, helping create the country’s largest chiropractic clinic network.

His appointment comes at an important moment as QC Kinetix enters a new period of advancement and expanded impact. With a rapidly growing network of locally owned clinics and an increasing presence across the country, QC Kinetix is preparing for the more complex demands that come with a larger national health care organization and footprint.

QC Kinetix selected Holt after watching him build The Joint into the country’s largest chiropractic clinic network. His combination of strategic vision, operational discipline and experience growing a health care organization makes him uniquely suited to guide QC Kinetix as it strengthens its infrastructure, expands its platform, broadens support for its franchisees and continues pursuing its long-term vision.

“Peter has led a leading national clinic network through and beyond this stage before,” said Justin Crowell, co-founder of QC Kinetix. “His priorities are to help our clinic owners succeed, strengthen our organization to support them and prepare our company for growth and scale to a larger national footprint.”

Crowell said the appointment reflects the company’s focus on preparing for the future while preserving the principles that have defined QC Kinetix.

“We are building from a position of strength and preparing our organization for acceleration and scale,” Crowell said. “Our physician leadership team will continue to guide all medical decisions and clinical standards. Peter will strengthen our systems, operations and business platform to best support our clinics, expand our capabilities and help us serve more communities.”

“QC Kinetix has built a patient-centered model that is gaining traction in communities across the country,” Holt said. “What attracted me was the combination of strong physician leadership, committed clinic owners and the opportunity to grow our impact by strengthening our infrastructure, supporting our clinics and staying true to what has made QC Kinetix successful.”

About QC Kinetix

Founded in 2017 and based in Charlotte, N.C., QC Kinetix is the largest regenerative medicine franchise in North America, recognized by the Inc. 5000 as one of America’s fastest-growing private companies. The brand delivers non-surgical, biologic-based treatments to help patients address joint pain, injuries and musculoskeletal conditions by stimulating the body’s natural healing processes. QC Kinetix began franchising in 2020 and now operates more than 100 clinics across the U.S., with continued national expansion underway.

Media Contact
Sonny Dill
256-591-5777
sonny@markstein.co

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414391429/en/

登錄即免費解鎖3,182字全文

因資訊版權原因,登錄長橋賬戶後方可瀏覽相關內容
感謝您對正版資訊的理解與支持

推薦閱讀

  • 2026年4月20日 晚上06:34禮來宣佈 70 億美元收購 Kelonia:佈局 “體內 CAR-T” 前沿賽道,引領基因療法變革
  • 2026年4月7日 晚上10:32提醒:日內請重點關注(以下均為北京時間)
  • 2026年4月1日 晚上11:11第一款隨時能吃的減肥藥來了!禮來 Foundayo 獲 FDA 批准,無需空腹、無需等待
  • 2026年3月25日 早上07:02不再 “單飛” 後,平安好醫生變強了
  • 2026年3月9日 下午04:15握手言和!諾和諾德撤回訴訟,Wegovy 正式登陸 Hims & Hers 平台

關聯股票

Geratherm Medical AG

Geratherm Medical AG

DEGME

JOINT

JOINT

USJYNT

+2.05%

醫療業 ETF - Vanguard

醫療業 ETF - Vanguard

USVHT

LongbridgeAI